Skip to main content

Table 3 – Cost effectiveness of different treatment paradigms for BP lowering relative to current practice

From: Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India

Treatment paradigm for BP lowering Population treated n (%) CVD events averted over 10 years due to treatment Treatment costs for patients at high risk of CVD (USD millions) Hospitalization costs for CVD events (USD millions) Incremental cost relative to current practice (USD millions) Incremental CVD events averted relative to current practice Incremental cost per CVD event averted relative to current practice (USD) Incremental cost per DALY averted relative to currentpractice (1 CVD event = 22.5 DALYs)a
Current practice 12,190 (19.6) 502 4.4 0.10     
Treatment of “hypertension” (BP > 140/90 mmHg) 13,061 (32.6) 869 7.3 0.18 2.8 367 7723.0 342.9
Treatment according to NPCDCS guidelines 13,061 (21.0) 886 4.7 0.18 0.2 384 608.3 27.0
Treatment of all at intermediate and high risk 14,429 (23.2) 936 5.2 0.19 0.7 434 1649.2 73.2
Treatment of all at high risk 11,133 (17.9) 812 4.0 0.17 −0.4 310 Cost saving Cost saving
Treatment of all above 45 years of age 47,578 (76.5) 1233 17.1 0.26 12.6 731 17,219.9 764.7
Treatment of all above 55 years of age 27,676 (44.5) 909 9.9 0.19 5.5 407 13,434.9 596.6
  1. aThe average burden associated with each cardiovascular event was calculated by dividing total burden in terms of disability adjusted life year (DALYs) lost due to coronary heart diseases with the total number of acute coronary events per year in India (28.6/1.27) [28, 29]
  2. BP blood pressure, CVD cardiovascular disease, NPCDCS National Program on prevention and control of Cancer, Diabetes, Cardiovascular diseases and Stroke, USD The United States dollar, DALY Disability-adjusted life year